These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33193362)

  • 1. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
    Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
    Front Immunol; 2020; 11():574447. PubMed ID: 33193362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.
    Lewis JS; Dolgova NV; Zhang Y; Xia CQ; Wasserfall CH; Atkinson MA; Clare-Salzler MJ; Keselowsky BG
    Clin Immunol; 2015 Sep; 160(1):90-102. PubMed ID: 25842187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.
    Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL
    Front Immunol; 2021; 12():653088. PubMed ID: 34122410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.
    Cho JJ; Stewart JM; Drashansky TT; Brusko MA; Zuniga AN; Lorentsen KJ; Keselowsky BG; Avram D
    Biomaterials; 2017 Oct; 143():79-92. PubMed ID: 28772190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
    Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
    Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct modulation of myelin-autoreactive CD4
    Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
    Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
    Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
    Penna G; Adorini L
    J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential.
    Li G; Kim YJ; Broxmeyer HE
    J Immunol; 2005 Apr; 174(8):4706-17. PubMed ID: 15814695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors.
    Li G; Abediankenari S; Kim YJ; Campbell TB; Ito S; Graham-Evans B; Cooper S; Broxmeyer HE
    Blood; 2007 Oct; 110(8):2872-9. PubMed ID: 17585053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.
    Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J
    J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).
    van Halteren AG; van Etten E; de Jong EC; Bouillon R; Roep BO; Mathieu C
    Diabetes; 2002 Jul; 51(7):2119-25. PubMed ID: 12086941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
    Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
    Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.
    Torres-Aguilar H; Sánchez-Torres C; Jara LJ; Blank M; Shoenfeld Y
    J Clin Immunol; 2010 Sep; 30(5):659-68. PubMed ID: 20544263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin Oligodendrocyte Glycoprotein (MOG)35-55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis.
    Rodi M; de Lastic AL; Panagoulias I; Aggeletopoulou I; Kelaidonis K; Matsoukas J; Apostolopoulos V; Mouzaki A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design principles of microparticle size and immunomodulatory factor formulation dictate antigen-specific amelioration of multiple sclerosis in a mouse model.
    Kwiatkowski AJ; Helm EY; Stewart J; Leon J; Drashansky T; Avram D; Keselowsky B
    Biomaterials; 2023 Mar; 294():122001. PubMed ID: 36716589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S; Ghasemi M
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.